ATE390937T1 - Methoden zur behandlung von hyperproliferativen krankheiten mit menschlichem mda-7 - Google Patents

Methoden zur behandlung von hyperproliferativen krankheiten mit menschlichem mda-7

Info

Publication number
ATE390937T1
ATE390937T1 AT00950382T AT00950382T ATE390937T1 AT E390937 T1 ATE390937 T1 AT E390937T1 AT 00950382 T AT00950382 T AT 00950382T AT 00950382 T AT00950382 T AT 00950382T AT E390937 T1 ATE390937 T1 AT E390937T1
Authority
AT
Austria
Prior art keywords
methods
mda
treating
human
hyperproliferative diseases
Prior art date
Application number
AT00950382T
Other languages
English (en)
Inventor
Abner Mhashilkar
Bob Schrock
Sunil Chada
Original Assignee
Introgen Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Introgen Therapeutics Inc filed Critical Introgen Therapeutics Inc
Application granted granted Critical
Publication of ATE390937T1 publication Critical patent/ATE390937T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT00950382T 1999-07-15 2000-07-13 Methoden zur behandlung von hyperproliferativen krankheiten mit menschlichem mda-7 ATE390937T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14435499P 1999-07-15 1999-07-15
US20076800P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
ATE390937T1 true ATE390937T1 (de) 2008-04-15

Family

ID=26841928

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00950382T ATE390937T1 (de) 1999-07-15 2000-07-13 Methoden zur behandlung von hyperproliferativen krankheiten mit menschlichem mda-7

Country Status (6)

Country Link
EP (1) EP1307234B1 (de)
AT (1) ATE390937T1 (de)
AU (1) AU6349400A (de)
CA (1) CA2379171A1 (de)
DE (1) DE60038508T2 (de)
WO (1) WO2001005437A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1650303B1 (de) 1993-10-27 2008-05-28 The Trustees of Columbia University of the City of New York Methode zur Bildung einer subtrahierten cDNA Bank und ihre Verwendung
US5710137A (en) 1996-08-16 1998-01-20 The Trustees Of Columbia University In The City Of New York Use of a melanoma differentiation associated gene (mda 7) for reversing a cancerous phenotype
CA2429769C (en) * 2000-12-07 2016-04-26 Board Of Regents, The University Of Texas System Methods of treatment involving human mda-7
US20030082140A1 (en) 2001-08-20 2003-05-01 Fisher Paul B. Combinatorial methods for inducing cancer cell death
EP1327688A1 (de) * 2002-01-14 2003-07-16 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Adenoviren mit erhöhter Lysisfähigkeit
US20040009939A1 (en) * 2002-03-05 2004-01-15 Board Of Regent, The University Of Texas System Methods of enhancing immune induction involving MDA-7
AU2003274963A1 (en) * 2002-12-23 2004-07-29 The Trustees Of Columbia University In The City Of New York Mda-7 and free radicals in the treatment of cancer
US8034790B2 (en) 2003-12-01 2011-10-11 Introgen Therapeutics Use of MDA-7 to inhibit pathogenic infectious organisms
EP2050458A1 (de) * 2007-10-17 2009-04-22 Institut National De La Sante Et De La Recherche Medicale (Inserm) IL24 zur Induzierung des Zelltodes hyperproliferativer oder autoimmuner Zellen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1650303B1 (de) * 1993-10-27 2008-05-28 The Trustees of Columbia University of the City of New York Methode zur Bildung einer subtrahierten cDNA Bank und ihre Verwendung
JP2001508652A (ja) * 1996-12-23 2001-07-03 シェーリング コーポレイション Ｉｌ１０に関連する哺乳動物サイトカイン

Also Published As

Publication number Publication date
EP1307234A2 (de) 2003-05-07
DE60038508T2 (de) 2009-04-30
WO2001005437A3 (en) 2003-02-06
DE60038508D1 (de) 2008-05-15
AU6349400A (en) 2001-02-05
CA2379171A1 (en) 2001-01-25
EP1307234B1 (de) 2008-04-02
WO2001005437A2 (en) 2001-01-25

Similar Documents

Publication Publication Date Title
Kawasaki et al. The mechanisms and evidence of efficacy of electrical stimulation for healing of pressure ulcer: a systematic review
SG146666A1 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
Chang et al. Lymphangiogenesis new mechanisms
ATE347366T1 (de) Verwendung von activem vitamin d analoga zur behandlung von prostataerkrangkungen
DE50002293D1 (de) Verwendung von csf-1-inhibitoren
WO1999040197A3 (en) Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
HUP9800028A2 (hu) Több tumor esetében rendellenes sejtszaporodás előidézésében közrejátszó gének
ATE354638T1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
WO2006014159A3 (en) Methods of using regenerative cells in the treatment of musculoskeletal disorders
ATE390937T1 (de) Methoden zur behandlung von hyperproliferativen krankheiten mit menschlichem mda-7
DE60230807D1 (de) Behandlung von sarkom bei menschen mit adenovirus-vektor tnf-alpha
DE69635349D1 (de) Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
ATE385807T1 (de) Pharmazeutische verbindung und methoden zur behandlung von menschlichen karzinomen mittels arginin entzug
WO2002045737A3 (en) Methods of treatment involving human mda-7
Guerriero et al. Effectiveness of an innovative pulsed electromagnetic fields stimulation in healing of untreatable skin ulcers in the frail elderly: two case reports
EA200001124A1 (ru) Способ генной терапии
ATE287722T1 (de) Mittel zur behandlung maligner erkrankungen unter verwendung des proteins yb-1
DE602005021159D1 (de) Bakteriophagen- und prophagen-proteine in der krebsgentherapie
ATE239492T1 (de) Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen
ATE513050T1 (de) Rekombinante genmedizin aus adenovirusvektor und gen p53 zur behandlung proliferativer erkrankungen
RU2270663C2 (ru) Способ терапии патологической пролиферации клеток организма
Balakatounis Electrical stimulation for wound healing
WO2003016343A3 (en) USE OF αCP1, αCP2, AND HUR FOR MODULATING GENE EXPRESSION AND INDUCING ANGIOGENESIS
MX9707617A (es) Factor de crecimiento de criptina humano.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1307234

Country of ref document: EP